Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Article Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
March 08, 2024
For nearly 25 years, innovation has been core to Gavi’s success in accelerating vaccine introductions in lower-income countries. Building on this track record, Gavi has a high-impact opportunity to sharpen its focus on scaling innovations for systems improvement in its next five-year strategic perio...
Blog Post
January 30, 2024
Since its launch in 2000, Gavi, the Vaccine Alliance, has leveraged three primary levers to expand equitable vaccine access in lower-income countries. First, Gavi supports introductions of new and underused vaccines. Second, Gavi helps scale equitable immunization coverage rates. Third, Gavi uses an...
POLICY PAPERS
January 30, 2024
For nearly 25 years, Gavi has delivered impact and value for money and remained one of the most successful global health initiatives. Gavi’s success has been driven by its use of three primary levers: (1) accelerating new vaccine introductions, (2) increasing equitable immunization coverage, and (3)...
Blog Post
December 14, 2023
Harsh fiscal prospects and broader shifts in the health landscape are creating challenges for Gavi’s approach to country eligibility and transition. To date, Gavi’s income-based eligibility model has functioned well during periods of sustained growth in low- and middle-income countries and has helpe...
POLICY PAPERS
December 14, 2023
The prevailing fiscal outlook alongside broader shifts in the health landscape have important implications for countries’ eligibility for support from Gavi, the Vaccine Alliance. Current projections are similar to pre-COVID estimates, but the cohort of transitioning countries face more challenging ...
Blog Post
December 04, 2023
In the aftermath of the COVID-19 pandemic, Gavi faces an unprecedented situation. Billions of dollars that it raised back in 2022 for COVAX—the global effort to provide COVID-19 vaccines to lower-income countries—remain unspent. These resources are substantial, exceeding the entire annual budget of ...
Blog Post
December 01, 2023
When Gavi’s board meets in Accra, Ghana, next week, advancing discussions on a new five-year strategic period, known as “Gavi 6.0,” will be a top agenda item. But conversations about Gavi’s future direction are also taking place against the backdrop of a leadership transition and a rapidly changing ...
Blog Post
November 29, 2023
Regulation plays a vital role in ensuring the quality, safety, and efficacy of vaccines—and a strong regulatory system is key to successfully expanding vaccine manufacturing. The Gavi Secretariat is currently fine-tuning the design of a new Advance Market Commitment (AMC)—a financial mechanism to su...
Blog Post
November 15, 2023
One of the most salient lessons from the pandemic is the need to diversify manufacturing capabilities and bolster supply resilience to avoid a repeat of the slow and inequitable vaccine roll out in African countries. To turn this lesson into action, the Gavi Secretariat is rapidly advancing plans fo...